Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug. An advisory panel for the U.S. Food and Drug Administration late Thursday voted 6-3 against AstraZeneca’s oral drug camizestrant intended for the treatment of a type of breast cancer tumor, citing concerns around trial design. The FDA generally…
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing…
AstraZeneca‘s stock rose over 3% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable shift…
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most valuable company. But its troubles are stacking up and today the stock trades at just a quarter of what it did at its peak less than two years ago. Pricing pressure, fierce competition, and pipeline setbacks have…
China’s President Xi Jinping (R) and Britain’s Prime Minister Keir Starmer shake hands before their meeting at the Great Hall of the People in Beijing on January 29, 2026. Carl Court | Afp | Getty Images Chinese businesses have pledged hundreds of millions of pounds’ worth of investment in the U.K. and struck new partnerships…
Pharma giant AstraZeneca will list on the New York Stock Exchange on Monday, days after it announced big commitments on the other side of the world. Like the rest of Big Pharma, the company has a balancing act. It wants a close relationship with the U.S., its biggest market, and the listing is intended to…
China’s President Xi Jinping (R) and Britain’s Prime Minister Keir Starmer shake hands before their meeting at the Great Hall of the People in Beijing on January 29, 2026. Carl Court | Afp | Getty Images BEIJING — Countries that shunned China during its trade dispute with the U.S. are now sending their leaders to…
British Prime Minister Keir Starmer at Downing Street on January 27, 2026 in London, England. Jack Taylor | Getty Images News | Getty Images BEIJING — Nearly 60 British businesses and cultural organizations will join U.K. Prime Minister Keir Starmer on his trip to China this week, the first such state visit in eight years….
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference — the biggest gathering of biotech and pharma execs, investors and analysts in…
The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy….
